Observational study evaluate pathology practice use artificial intelligence in patient suspected lung and breast cancer

Trial Identifier:	D4191R00089
Sponsor:	AstraZeneca
Start Date:	March 2025
Primary Completion Date:	May 2027
Study Completion Date:	May 2027
Condition:	Breast Cancer; Lung Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.